Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
T. Muranaka
The comparison between UGT1A1 single heterozygous and wild-type regarding the clinical outcomes of fixed-dose irinotecan monotherapy for advanced gastric cancer: a multicenter retrospective study
Introduction Irinotecan is a key drug for advanced gastric cancer (AGC). We previously reported that patients with UGT1A1 single heterozygous (SH) had a significantly high frequency of s...
T. Miyagishima ;
A. Tanimoto ;
S. Yuki ;
T. Honda ;
Y. Komatsu ;
Y. Kobayashi ;
T. Sasaki ;
Y. Kawamoto ;
A. Ishiguro ;
K. Hatanaka ;
M. Dazai ;
H. Nakatsumi ;
Tomo Ando , MD;
H. Yoshita ;
S. Nakano ;
K. Sawada ;
T. Muranaka ;
K. Harada ;
07/01/2019
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Upcoming Events
February 2 – February 5
February 27 – March 1
March 17 – March 19
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 4
April 30 – May 5
May 1 – May 3
May 19 – May 21
See Full Calendar